分析倍他乐克联合通心络治疗冠心病心绞痛的临床效果

Clinical effect of Betaloc combined with Tongxinluo in the treatment of coronary heart disease and angina pectoris

目的分析冠心病心绞痛患者实施倍他乐克联合通心络治疗的价值。方法74例冠心病心绞痛患者,以随机抽签法分为对照组及观察组,每组37例。对照组行倍他乐克治疗,观察组在对照组基础上联合通心络治疗。比较两组患者的临床疗效,治疗前后的血脂指标(甘油三酯、总胆固醇、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇)水平。结果观察组治疗总有效率为94.59%,高于对照组的75.68%,差异具有统计学意义(χ^(2)=5.2323,P=0.0222<0.05)。治疗前,两组患者的甘油三酯、总胆固醇、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇比较,差异无统计学意义(P>0.05);治疗后,观察组患者的甘油三酯(2.05±0.21)mmol/L、总胆固醇(6.08±1.15)mmol/L、低密度脂蛋白胆固醇(3.01±0.74)mmol/L均低于对照组的(2.48±0.24)、(7.46±1.17)、(3.62±0.63)mmol/L,高密度脂蛋白胆固醇(1.48±0.71)mmol/L高于对照组的(1.19±0.40)mmol/L,差异具有统计学意义(P<0.05)。结论冠心病心绞痛患者予以倍他乐克联合通心络治疗,能取得更加理想的治疗效果,并促进患者血脂水平改善,值得临床重视推行。

Objective To analyze the value of Betaloc combined with Tongxinluo in the treatment of coronary heart disease and angina pectoris.Methods A total of 74 patients with coronary heart disease and angina pectoris were divided into the control group and the observation group by random lottery method,with 37 cases in each group.The control group was treated with Betaloc,and the observation group was treated with Tongxinluo based on the control group.Both groups were compared in terms of clinical efficacy and blood lipid indexes(triglyceride,total cholesterol,high density lipoprotein cholesterol,low density lipoprotein cholesterol)before and after treatment.Results The total effective rate of the observation group was 94.59%,which was higher than that of 75.68%of the control group,and the difference was statistically significant(χ^(2)=5.2323,P=0.0222<0.05).Before treatment,there was no statistically significant difference in triglyceride,total cholesterol,high density lipoprotein cholesterol and low density lipoprotein cholesterol between the two groups(P>0.05).After treatment,the observation group had triglycerides of(2.05±0.21)mmol/L,total cholesterol of(6.08±1.15)mmol/L and low density lipoprotein cholesterol of(3.01±0.74)mmol/L,which were lower than those of(2.48±0.24),(7.46±1.17)and(3.62±0.63)mmol/L in the control group;the high density lipoprotein cholesterol of(1.48±0.71)mmol/L in the observation group was higher than that of(1.19±0.40)mmol/L in the control group;the difference were statistically significant(P<0.05).Conclusion The combination of Betaloc and Tongxinluo in patients with coronary heart disease and angina pectoris can achieve more ideal therapeutic effect and promote the improvement of blood lipid level of patients,which is worth clinical attention.